Today, The Lancet published an article from researchers at the University of Pittsburgh Medical Center about a new potential vaccine for COVID-19. The vaccine generates a potent, antigen-specific antibody response to the virus. The vaccine has been effective in mouse trials thus far. Further, the researchers were successful in designing an effective method of administration of the vaccine that can be manufactured on a large-scale. Below are the links for the journal article, as well as a news report on the vaccine that is lighter on the science side.
Lancet article
https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(20)30118-3.pdf
News report
https://www.upmc.com/media/news/040220-falo-gambotto-sars-cov2-vaccine